| Website | tacerebio.com |
| Category | BioTech |
| Phone | (408) 960-2205 |
| info@tacerebio.com | |
| Employees | |
| Description | development of novel therapeutics |
| VENTURE FUNDING | |
| Seed, 10/06 Hokkaido Venture Capital |
Tacere Therapeutics, Inc. specializes in the development of novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). Combining expertise in RNA interference (RNAi), gene medicine, and novel biologicals, Tacere possesses proprietary skill in the identification and development of RNAi therapeutics.
